Effectiveness of Homoeopathy as an ancillary mode of treatment and management in combating Corona Virus infection - A Randomized, placebo-controlled, Single Blind Trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Primary outcome of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or death.
研究概览
简要总结
Theprimary aim of this study is to assess the effectiveness of Homoeopathy as anancillary mode of treatment to the standard treatment protocol for coronavirus.Throughthis study we will also be able to assess the time of recovery in the casewhere patient is experiencing severe acute respiratory syndrome. This willultimately prove to be effective in tackling infected patients having acuterespiratory syndrome where homoeopathic intervention will prove to bebeneficial for their recovery. It will also help in assessing the time ofrecovery of virulent symptoms. During the study, homoeopathic intervention willbe given to the patients and calculation of relapse rate will be done for thesepatients. People with pre existing medical conditions appear to be morevulnerable to becoming severely ill with the virus. Effective Homoeopathic treatmentfor this section of patients can be a game changer in the standard treatmentprotocol for Corona virus.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 5.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •â€¢Patients suffering from COVID-19 along with subjective and objective symptoms.
- •â€¢Patients with age groups of 5-70 years.
- •â€¢Patients of both genders.
- •â€¢Patients who are willing to give informed consent.
排除标准
- •â€¢More than 70 years of age and less than age of 5 years.
- •â€¢Pregnant females and lactating females.
- •â€¢Subjects considered not suitable for the study by the researchers.
结局指标
主要结局
Primary outcome of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or death.
时间窗: 21 days
次要结局
- Recovery in the case where patient is experiencing severe acute respiratory syndrome(2 hours)
- Decrease in the usage of life supportive equipment like ventilator usage, etc(5 days)
- Improvement in the quality of life including virulent symptoms of the patients(24 hours)
- Decrease in the frequency of the dosage of drugs of modern medicine/ conventional treatment according to the standard treatment protocol.(3 days)